Mesa Laboratories Inc’s (NASDAQ:MLAB) Sentiment is 2.42

September 13, 2017 - By Marguerite Chambers

 Mesa Laboratories Inc's (NASDAQ:MLAB) Sentiment is 2.42

Sentiment for Mesa Laboratories Inc (NASDAQ:MLAB)

Mesa Laboratories Inc (NASDAQ:MLAB) institutional sentiment increased to 2.42 in Q4 2016. Its up 0.96, from 1.46 in 2016Q3. The ratio has improved, as 46 active investment managers started new or increased stock positions, while 19 reduced and sold stock positions in Mesa Laboratories Inc. The active investment managers in our partner’s database now possess: 2.16 million shares, up from 2.07 million shares in 2016Q3. Also, the number of active investment managers holding Mesa Laboratories Inc in their top 10 stock positions was flat from 1 to 1 for the same number . Sold All: 2 Reduced: 17 Increased: 36 New Position: 10.

Mesa Laboratories, Inc. is focused primarily on quality control services and products. The company has market cap of $530.27 million. The Firm operates through four divisions: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. It has a 50.67 P/E ratio. The Instruments Division designs, makes and markets quality control instruments and disposable products.

The stock increased 1.20% or $1.67 during the last trading session, reaching $141.07. About 18,235 shares traded. Mesa Laboratories, Inc. (NASDAQ:MLAB) has risen 44.42% since September 13, 2016 and is uptrending. It has outperformed by 27.72% the S&P500.

Conestoga Capital Advisors Llc holds 3.12% of its portfolio in Mesa Laboratories, Inc. for 381,280 shares. Kistler owns 17,936 shares or 1.08% of their US portfolio. Moreover, Teton Advisors Inc. has 0.42% invested in the company for 34,300 shares. The Colorado-based Rocky Mountain Advisers Llc has invested 0.3% in the stock. Punch & Associates Investment Management Inc., a Minnesota-based fund reported 21,210 shares.#img1#

Since January 1, 0001, it had 0 insider purchases, and 4 sales for $2.54 million activity.

More important recent Mesa Laboratories, Inc. (NASDAQ:MLAB) news were published by: which released: “Mesa Laboratories, Inc. (MLAB) Ex-Dividend Date Scheduled for August 29, 2017” on August 28, 2017, also published article titled: “Mesa Labs posts 3Q profit”, published: “Mesa Laboratories (MLAB) Says Gary Owens to Succeed John Sullivan as CEO …” on September 01, 2017. More interesting news about Mesa Laboratories, Inc. (NASDAQ:MLAB) was released by: and their article: “Mesa Labs Acquires Hospital-Focused Cold Chain Monitoring Business” with publication date: November 07, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.